Peter Schubert

9.3k total citations · 1 hit paper
174 papers, 7.6k citations indexed

About

Peter Schubert is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Peter Schubert has authored 174 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Cellular and Molecular Neuroscience, 61 papers in Molecular Biology and 40 papers in Physiology. Recurrent topics in Peter Schubert's work include Neuroscience and Neuropharmacology Research (65 papers), Adenosine and Purinergic Signaling (40 papers) and Blood transfusion and management (26 papers). Peter Schubert is often cited by papers focused on Neuroscience and Neuropharmacology Research (65 papers), Adenosine and Purinergic Signaling (40 papers) and Blood transfusion and management (26 papers). Peter Schubert collaborates with scholars based in Germany, Canada and Italy. Peter Schubert's co-authors include Georg W. Kreutzberg, Karl Asmund Rudolphi, Jochen Gehrmann, Richard B. Banati, Dana V. Devine, G. W. Kreutzberg, Kevin M. Lee, Joyce A. DeLeo, Tadanori Ogata and Martin Reddington and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Peter Schubert

169 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytotoxicity of microglia

1993 892 citations Richard B. Banati, Jochen Gehrmann et al. Glia profile →

Peers

Countries citing papers authored by Peter Schubert

Since Specialization

Citations

This map shows the geographic impact of Peter Schubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schubert more than expected).

Fields of papers citing papers by Peter Schubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Schubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schubert. The network helps show where Peter Schubert may publish in the future.

Co-authorship network of co-authors of Peter Schubert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Schubert. A scholar is included among the top collaborators of Peter Schubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Schubert. Peter Schubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preparing small‐dose red cell concentrates (RCCs) for neonatal and pediatric transfusions: Impact of RCC volume, storage, and irradiation 2022 ·Transfusion ·(unknown), (unknown), (unknown), (unknown), (unknown), Gwen Clarke, (unknown), (unknown), Debra Lane, Peter Schubert, (unknown), Jason P. Acker	2
2	Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols 2017 ·Transfusion ·(unknown), Peter Schubert, Katherine Serrano, Cedric J. Carter, Brankica Culibrk, Dana V. Devine	13
3	Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm‐derived Staphylococcus epidermidis in buffy coat platelet concentrates 2017 ·Vox Sanguinis ·Mariam Taha, Brankica Culibrk, M. Kaláb, Peter Schubert, Qilong Yi, Raymond P. Goodrich, Sandra Ramírez‐Arcos	14
4	Altered timing of riboflavin and ultraviolet light pathogen inactivation improves platelet in vitro quality 2017 ·Transfusion ·Peter Schubert, Brankica Culibrk, (unknown), Katherine Serrano, E.J. Levin, Qilong Yi, Thomas Thiele, Andreas Greinacher, Susanne Marschner, Dana V. Devine	9
5	RhoA/ROCK signaling contributes to sex differences in the activation of human platelets 2016 ·Thrombosis Research ·Peter Schubert, (unknown), (unknown), (unknown), Dana V. Devine	13
6	Proteome Changes in Platelets After Pathogen Inactivation—An Interlaboratory Consensus 2014 ·Transfusion Medicine Reviews ·Michel Prudent, Angelo D’Alessandro, Jean‐Pierre Cazenave, Dana V. Devine, Christian Gachet, Andreas Greinacher, Niels Lion, Peter Schubert, Leif Steil, Thomas Thiele, Jean‐Daniel Tissot, Uwe Völker, Lello Zolla	75
7	Impact of sample volume and handling time during analysis on the in vitro quality measurements of platelet concentrates held in syringes 2011 ·International Journal of Laboratory Hematology ·Peter Schubert, Brankica Culibrk, (unknown), E.J. Levin, Dana V. Devine	4
8	A signaling pathway contributing to platelet storage lesion development: targeting PI3‐kinase–dependent Rap1 activation slows storage‐induced platelet deterioration 2009 ·Transfusion ·Peter Schubert, Jonathan N. Thon, (unknown), (unknown), Edwin D.W. Moore, Dana V. Devine, Juergen Kast	32
9	Proteomics meets blood banking: Identification of protein targets for the improvement of platelet quality 2009 ·Journal of Proteomics ·Peter Schubert, Dana V. Devine	35
10	Differential regulation of microglial activation by propentofylline via cAMP signaling 1998 ·Brain Research ·Qiusheng Si, Yoichi Nakamura, Tadanori Ogata, Kiyoshi Kataoka, Peter Schubert	72
11	Errata and corrigenda 1996 ·FEBS Letters ·Antonella Isacchi, Giacomo Bernardi, Giorgio Bernardi, Stefano Ferroni, Cristina Marchini, Peter Schubert, C Rapisarda, (unknown), (unknown)	1
12	Extracellular PagC-HlyA S fusion protein for the generation and identification of Salmonella -specific antibodies 1996 ·Applied Microbiology and Biotechnology ·Hans‐Joachim Mollenkopf, Ivaylo Gentschev, Andreas Bubert, Peter Schubert, (unknown)	11
13	Adenosine and Brain Ischemia 1995 ·PubMed ·Karl Asmund Rudolphi, Peter Schubert	239
14	Cytotoxicity of microglia breakdown → 1993 ·Glia ·Richard B. Banati, Jochen Gehrmann, Peter Schubert, Georg W. Kreutzberg	892
15	Neuroprotective role of adenosine in cerebral ischaemia 1992 ·Trends in Pharmacological Sciences ·Karl Asmund Rudolphi, Peter Schubert, Fiona E. Parkinson, Bertil B. Fredholm	377
16	Adenosine modulates a voltage-dependent chloride conductance in cultured hippocampal neurons 1990 ·Brain Research ·Ralph Mager, Stefano Ferroni, Peter Schubert	60
17	Effect of carbamazepine on stimulus-evoked Ca2+ fluxes in rat hippocampal slices and its interaction with A1-adenosine receptors 1988 ·Neuroscience Letters ·Thomas Gasser, Martin Reddington, Peter Schubert	13
18	Adenosine : receptors and modulation of cell function : proceedings of the International Workshop on Adenosine and Xanthine derivatives 1985 ·(unknown), V. Stefanovich, Karl Asmund Rudolphi, Peter Schubert	5
19	Parameters of dendritic transport. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Peter Schubert, Kreutzberg Gw	17
20	Enzymhistochemie menschlicher Hirntumoren und ihrer Gewebekultur: II. Oxydoreduktasen in Ependymomen mit quantitativen Befunden 1967 ·Histochemistry and Cell Biology ·Peter Schubert, Georg W. Kreutzberg	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact